Literature DB >> 3366898

Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor.

X M Sun1, W Hsueh.   

Abstract

We have developed a rat model of ischemic bowel necrosis associated with shock by injection of platelet-activating factor (PAF) or a combination of PAF and endotoxin. Recent investigations have shown that tumor necrosis factor (TNF) also induces shock and necrosis of the gastrointestinal tract. The morphological changes of TNF-induced bowel lesions are indistinguishable from those caused by PAF. The mechanism of TNF-induced bowel necrosis is unclear. In the present study, we have shown that (a) TNF caused PAF production in bowel tissue; (b) the effects of TNF and LPS on PAF production in the intestine are additive; (c) TNF and LPS are synergistic in inducing bowel necrosis; and (d) TNF-induced bowel necrosis is due to PAF release and can be prevented by pretreatment with PAF antagonists.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366898      PMCID: PMC442560          DOI: 10.1172/JCI113459

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

Review 3.  Background and present status of research on platelet-activating factor (PAF-acether).

Authors:  B B Vargaftig; M Chignard; J Benveniste; J Lefort; F Wal
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.

Authors:  M Halonen; J D Palmer; I C Lohman; L M McManus; R N Pinckard
Journal:  Am Rev Respir Dis       Date:  1980-12

5.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

6.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

Authors:  F Gonzalez-Crussi; W Hsueh
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

7.  Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.

Authors:  M Sánchez-Crespo; F Alonso; P Iñarrea; V Alvarez; J Egido
Journal:  Immunopharmacology       Date:  1982-04

8.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

9.  Purification of rabbit tumor necrosis factor.

Authors:  S Abe; T Gatanaga; M Yamazaki; G Soma; D Mizuno
Journal:  FEBS Lett       Date:  1985-01-28       Impact factor: 4.124

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  72 in total

1.  Thalidomide reduces tumour necrosis factor alpha and interleukin 12 production in patients with chronic active Crohn's disease.

Authors:  J Bauditz; S Wedel; H Lochs
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

2.  Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells.

Authors:  R A Barthelson; F H Valone
Journal:  Lipids       Date:  1991-03       Impact factor: 1.880

Review 3.  PAF. A review of its effects, antagonists and possible future clinical implications (Part II).

Authors:  M Koltai; D Hosford; P Guinot; A Esanu; P Braquet
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

Authors:  F D Pagani; L S Baker; C Hsi; M Knox; M P Fink; M S Visner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

5.  Effects of platelet-activating factor on lipid metabolism in rats in vivo. Origin of the hypertriglyceridaemia.

Authors:  R D Evans; V Ilic; D H Williamson
Journal:  Biochem J       Date:  1991-12-01       Impact factor: 3.857

6.  Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators.

Authors:  Catherine J Hunter; Isabelle G De Plaen
Journal:  Pathophysiology       Date:  2013-12-31

7.  Disparate effects of interferon-gamma and tumor necrosis factor-alpha on early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro.

Authors:  R D Diamond; C A Lyman; D R Wysong
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 8.  Significance of lipid mediators in corneal injury and repair.

Authors:  Sachidananda Kenchegowda; Haydee E P Bazan
Journal:  J Lipid Res       Date:  2009-11-03       Impact factor: 5.922

9.  Inhibition of endotoxin-induced bacterial translocation in mice.

Authors:  E A Deitch; L Ma; W J Ma; M B Grisham; D N Granger; R D Specian; R D Berg
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

10.  Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor.

Authors:  X Sun; M S Caplan; W Hsueh
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.